SAFE ORTHOPAEDICS SA Inactive Instrument
Safe Orthopaedics SA Stock CBOE EUROPE EQUITIES
Equities
0RAA
FR0013467123
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2021 | 4.55M 4.9M 6.71M | Sales 2022 | 5.86M 6.31M 8.63M | Capitalization | 55.78K 60.05K 82.14K |
|---|---|---|---|---|---|
| Net income 2021 | -6M -6.46M -8.84M | Net income 2022 | -6M -6.46M -8.84M | EV / Sales 2021 | 4.43 x |
| Net Debt 2021 | 7.95M 8.56M 11.7M | Net Debt 2022 | 9.58M 10.32M 14.12M | EV / Sales 2022 | 1.64 x |
| P/E ratio 2021 |
-2.1
x | P/E ratio 2022 |
-526
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 10% |
More Fundamentals
* Assessed data
More news
Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). Net sales break down by distribution channel as follows:
- direct sale (45%): activity carried out in France, Germany and the United Kingdom;
- indirect sale (18%).
The remaining sales (37%) are from from sub-contract manufacturing of medical devices for orthopedic surgery (Safe Medical).
| 1st Jan change | Capi. | |
|---|---|---|
| +8.70% | 124B | |
| +6.05% | 9.31B | |
| +23.36% | 7.6B | |
| +32.10% | 5.29B | |
| +8.61% | 3.45B | |
| -9.10% | 2.79B | |
| -2.71% | 2.3B | |
| -0.20% | 2.23B | |
| -20.42% | 1.86B |
- Stock Market
- Equities
- ALSAF Stock
- 0RAA Stock